Ikarian Capital »

Sensei Biotherapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $389k 650k 0.60
2024-06-30 $403k 650k 0.62

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Sensei Biotherapeutics

Ikarian Capital
Vanguard Group
Renaissance Technologies
Geode Capital Management
Susquehanna International
Bridgeway Capital Management
Citadel Advisors
National Bank Of Canada /fi/
Northern Trust
State Street Corporation
Raymond James & Associates
Two Sigma Securities
Morgan Stanley
Deuterium Capital Management
BlackRock

View all funds holding Sensei Biotherapeutics